lisinopril and hydrochlorothiazide (51407-566)

Drug Facts

Product Profile

Brand Name lisinopril and hydrochlorothiazide

Generic Name lisinopril and hydrochlorothiazide

Labeler gsms, incorporated

Dosage Form TABLET

Routes

ORAL

Active Ingredients

hydrochlorothiazide 25 mg/1, lisinopril 20 mg/1

Manufacturer

GSMS, Incorporated

Identifiers & Regulatory

Product NDC 51407-566

Product ID 51407-566_fd91c3d4-99e0-4b5d-8f6c-d08f19b64703

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA076674

Listing Expiration 2026-12-31

Marketing Start 2025-02-15

Pharmacologic Class

Established (EPC)

thiazide diuretic [epc]

Chemical Structure

thiazides [cs]

Physiologic Effect

increased diuresis [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 51407566

Hyphenated Format 51407-566

Supplemental Identifiers

RxCUI

197885 197886 197887

UPC

0351407565907 0351407566904 0351407565051 0351407566058 0351407564054 0351407564900

UNII

0J48LPH2TH E7199S1YWR

NUI

N0000175359 N0000175419 M0471776

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lisinopril and hydrochlorothiazide (source: ndc)

Generic Name lisinopril and hydrochlorothiazide (source: ndc)

Application Number ANDA076674 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

25 mg/1
20 mg/1

source: ndc

Packaging

500 TABLET in 1 BOTTLE (51407-566-05)
90 TABLET in 1 BOTTLE (51407-566-90)

source: ndc

Packages (2)

51407-566-05 500 TABLET in 1 BOTTLE (51407-566-05) 51407-566-90 90 TABLET in 1 BOTTLE (51407-566-90)

Ingredients (2)

hydrochlorothiazide (25 mg/1) lisinopril (20 mg/1)

Linked Drug Pages (1)

LISINOPRIL and HYDROCHLOROTHIAZIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "fd91c3d4-99e0-4b5d-8f6c-d08f19b64703", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "upc": ["0351407565907", "0351407566904", "0351407565051", "0351407566058", "0351407564054", "0351407564900"], "unii": ["0J48LPH2TH", "E7199S1YWR"], "rxcui": ["197885", "197886", "197887"], "spl_set_id": ["d02a0d38-676a-4e0f-9aa2-0a6c56cd7361"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["GSMS, Incorporated"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET in 1 BOTTLE (51407-566-05)", "package_ndc": "51407-566-05", "marketing_start_date": "20250215"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (51407-566-90)", "package_ndc": "51407-566-90", "marketing_start_date": "20250215"}], "brand_name": "LISINOPRIL and HYDROCHLOROTHIAZIDE", "product_id": "51407-566_fd91c3d4-99e0-4b5d-8f6c-d08f19b64703", "dosage_form": "TABLET", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "51407-566", "generic_name": "LISINOPRIL and HYDROCHLOROTHIAZIDE", "labeler_name": "GSMS, Incorporated", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LISINOPRIL and HYDROCHLOROTHIAZIDE", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "25 mg/1"}, {"name": "LISINOPRIL", "strength": "20 mg/1"}], "application_number": "ANDA076674", "marketing_category": "ANDA", "marketing_start_date": "20250215", "listing_expiration_date": "20261231"}